From SGI yesterday:
Discovering the differences and changes within the genome that trigger disease is a priority for The Translational Genomics Research Institute (TGen). To aid the non-profit research institute in their quest, TGen deployed technology from SGI (NASDAQ: SGIC) to more quickly analyze molecular profile data sets in their search for cancer cures. Purchased in April through a National Institute of Health (NIH) grant, the SGI Altix 4700 will assist TGen researchers in understanding the genomic variation — a process which requires comparison searches of enormous data sets — that can be rapidly used for diagnosis and treatment of disease in a manner tailored to individual patients.
TGen’s SGI Altix 4700 is equipped with 576GB memory and 48 Intel Itanium 2 cores.